Midwest Trust Co Takes Position in HCA Healthcare, Inc. $HCA

Midwest Trust Co bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 892 shares of the company’s stock, valued at approximately $342,000.

A number of other institutional investors also recently added to or reduced their stakes in the stock. Cheviot Value Management LLC bought a new position in HCA Healthcare in the first quarter worth about $26,000. Saudi Central Bank purchased a new stake in HCA Healthcare during the first quarter valued at approximately $26,000. WPG Advisers LLC purchased a new position in HCA Healthcare in the first quarter worth $27,000. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the 2nd quarter valued at $27,000. Finally, Chung Wu Investment Group LLC purchased a new position in HCA Healthcare during the 2nd quarter worth $27,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Trading Up 2.5%

Shares of HCA stock opened at $474.08 on Thursday. The stock has a market cap of $108.18 billion, a P/E ratio of 18.33, a P/E/G ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $479.43. The stock has a 50 day moving average of $431.29 and a 200 day moving average of $394.54.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the firm earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

Analysts Set New Price Targets

HCA has been the topic of a number of research analyst reports. Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. UBS Group upped their price target on shares of HCA Healthcare from $495.00 to $525.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Royal Bank Of Canada boosted their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a report on Monday, October 27th. Robert W. Baird raised their target price on HCA Healthcare from $380.00 to $423.00 and gave the stock a “neutral” rating in a research note on Thursday, August 14th. Finally, Jefferies Financial Group increased their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.